Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 23, 2024Expert Review of Clinical Pharmacology

Is a low dose of dexamethasone sufficient to prevent paclitaxel-related hypersensitivity reactions? A retrospective study in patients with gynecologic malignancy

View Full Paper
Ask AI
Bookmark
Share

Authors

DXDi XiaoTwitter (United States)ZYZhiyun YangChongqing UniversityYSYin ShiZhejiang University

Discussion

Loading...

Member takes

Overview

Retrospective study evaluates low-dose dexamethasone for preventing paclitaxel hypersensitivity reactions in gynecologic cancer, highlighting strategies to preserve chemotherapy efficacy.

Key Points

  • Low-dose dexamethasone was evaluated to mitigate paclitaxel hypersensitivity reactions while avoiding adverse impacts on overall chemotherapy efficacy.
  • Retrospective study records reviewed clinical outcomes to identify the lowest dexamethasone dose sufficient for patients receiving paclitaxel therapy.
  • Dexamethasone reduction may prevent the steroid from accelerating tumor progression or reducing chemotherapy efficacy during cancer management.

Cite This Study

Xiao et al. (2024) studied this question.

synapsesocial.com/papers/68e6df92b6db64358765b0d2https://doi.org/10.1080/17512433.2024.2343852
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Models for Longitudinal Data: A Generalized Estimating Equation Approach1988 · 4,569 citations
  2. 2Cancer of the cervix uteri2018 · 1,162 citations
  3. 3Sex and Gender Aspects for Patient Stratification in Allergy Prevention and Treatment2020 · 97 citations
  4. 4Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity Reactions2021 · 38 citations
  5. 5Paclitaxel-Associated Hypersensitivity Reactions: Experience of the Gynecologic Oncology Program of the Cleveland Clinic Cancer Center2000 · 192 citations